🇺🇸 FDA
Pipeline program

BRONCHO-VAXOM Children Capsules placebo, BRONCHO-VAXOM, 3,5mg, kapsułki

BV-2020/09

Phase 2 small_molecule active

Quick answer

BRONCHO-VAXOM Children Capsules placebo, BRONCHO-VAXOM, 3,5mg, kapsułki for Recurrent wheezing is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Recurrent wheezing
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials